Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma-Reference-Cited by-同舟云学术

Development and validation of a high‐sensitivity assay for measuring p217+tau in plasma

Published:2021-01 Issue:1 Volume:13 Page:
ISSN:2352-8729
Container-title:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
language:en
Short-container-title:Alz & Dem Diag Ass & Dis Mo

Author:

Triana‐Baltzer Gallen¹^ORCID,Moughadam Setareh¹,Slemmon Randy¹,Van Kolen Kristof²,Theunis Clara²,Mercken Marc²,Kolb Hartmuth C.¹

Affiliation:

1. Neuroscience Biomarkers Janssen Research & Development La Jolla California USA

2. Neuroscience Department Janssen Research & Development Beerse Belgium

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dad2.12204

Reference44 articles.

1. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census

2. Deaths: leading causes for 2016;Heron M;Natl Vital Stat Rep,2018

3. www.alz.org/alzheimers‐dementia/facts‐figures

4. Application of the NIA‐AA research framework: towards a biological definition of Alzheimer's disease using cerebrospinal fluid biomarkers in the AIBL study;Burnham SC;J Prev Alz Dis,2019

5. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts;Alzheimer's Research & Therapy;2024-07-22

2. A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker Tests;2024-07-05

3. Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease;Communications Biology;2024-05-04

4. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology;Nature Communications;2024-03-23

5. Plasma pTau‐217 and N‐terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid‐β positive individuals;Alzheimer's & Dementia;2023-11-03